Orthofix Medical Stock Analysis

Orthofix Stock Analysis Notes

About 91.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.18. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Orthofix Medical has Price/Earnings (P/E) ratio of 338.0. The entity recorded a loss per share of 3.03. The firm had not issued any dividends in recent years. Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. Orthofix Intl operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1087 people. To find out more about Orthofix Medical contact Massimo Calafiore at 214 937 2000 or learn more at https://orthofix.com.

Orthofix Medical Investment Alerts

Orthofix Largest EPS Surprises

View All Earnings Estimates

Orthofix Medical Environmental, Social, and Governance (ESG) Scores

Orthofix Medical Thematic Classifications

Orthofix Stock Institutional Investors

Note, although Orthofix Medical's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Orthofix Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 532.62 M.

Orthofix Profitablity

The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.08) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.08.

Management Efficiency

Orthofix Medical has return on total asset (ROA) of (0.0546) % which means that it has lost $0.0546 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.246) %, meaning that it created substantial loss on money invested by shareholders. Orthofix Medical's management efficiency ratios could be used to measure how well Orthofix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to rise to -0.23 in 2026. Return On Capital Employed is likely to drop to -0.13 in 2026. At this time, Orthofix Medical's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 555.5 M in 2026, whereas Intangible Assets are likely to drop slightly above 57.6 M in 2026.

Technical Drivers

As of the 3rd of February, Orthofix Medical holds the Coefficient Of Variation of (917.92), risk adjusted performance of (0.07), and Variance of 4.87. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Orthofix Medical, as well as the relationship between them.

Orthofix Medical Price Movement Analysis

Orthofix Medical Insider Trading Activities

Orthofix Medical Predictive Daily Indicators

Orthofix Medical Corporate Filings

Orthofix Medical Forecast Models

Orthofix Medical's time-series forecasting models are one of many Orthofix Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Orthofix Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Orthofix Medical Debt to Cash Allocation

Orthofix Medical currently holds 179.63 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Orthofix Medical has a current ratio of 3.09, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Orthofix Medical's use of debt, we should always consider it together with its cash and equity.

Orthofix Medical Common Stock Shares Outstanding Over Time

Orthofix Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Orthofix Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Orthofix Medical Debt Ratio

13.0

It appears most of the Orthofix Medical's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Orthofix Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Orthofix Medical, which in turn will lower the firm's financial flexibility.

Orthofix Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Orthofix Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Orthofix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Orthofix Medical. By using and applying Orthofix Stock analysis, traders can create a robust methodology for identifying Orthofix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Orthofix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Orthofix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Orthofix Medical stock analysis indicators help investors evaluate how Orthofix Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Orthofix Medical shares will generate the highest return on investment. By understating and applying Orthofix Medical stock analysis, traders can identify Orthofix Medical position entry and exit signals to maximize returns.

When running Orthofix Medical's price analysis, check to measure Orthofix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orthofix Medical is operating at the current time. Most of Orthofix Medical's value examination focuses on studying past and present price action to predict the probability of Orthofix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orthofix Medical's price. Additionally, you may evaluate how the addition of Orthofix Medical to your portfolios can decrease your overall portfolio volatility.